Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and durapatite

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with durapatite in 2 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Trials
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Studies
(durapatite)
Trials
(durapatite)
Recent Studies (post-2010) (durapatite)
254817,1015227,832

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kickelbick, G; Kolar, ZI; Peters, JA; Rill, C; Wolterbeek, HT1
Chakraborty, S; Chakravarty, R; Dash, A; Kamaleshwaran, K; Radhakrishnan, E; Rajeswari, A; Sarma, HD; Shinto, AS; Vimalnath, KV1

Other Studies

2 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and durapatite

ArticleYear
Kinetics and thermodynamics of adsorption on hydroxyapatite of the [160Tb]terbium complexes of the bone-targeting ligands DOTP and BPPED.
    Langmuir : the ACS journal of surfaces and colloids, 2009, Feb-17, Volume: 25, Issue:4

    Topics: Adsorption; Bone and Bones; Durapatite; Kinetics; Ligands; Molecular Structure; Organophosphorus Compounds; Porphyrins; Radioisotopes; Temperature; Terbium; Thermodynamics

2009
A "mix-and-use" approach for formulation of human clinical doses of
    Journal of labelled compounds & radiopharmaceuticals, 2017, Volume: 60, Issue:9

    Topics: Animals; Bone Neoplasms; Cancer Pain; Durapatite; Humans; Lutetium; Male; Organophosphorus Compounds; Pharmacy Service, Hospital; Radioisotopes; Rats; Tissue Distribution

2017